Drugs and Diagnostics for Hematological Disorders: Global Markets

Sep 2016| PHM116B| BCC Publishing

Report Highlights

The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020.

Report Includes

  • An overview of the global market for drugs and diagnostics for hematological disorders.
  • Analyses of global market trends, with data from2015, and projections of CAGRs through 2020.
  • A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics.
  • A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Delineation of drugs approved by the FDA for hematological disorders.
  • Profiles of key companies in the industry.

SCOPE OF THE STUDY

The scope of this study covers instruments, reagents, testing, screening technology and the therapeutics markets for hematological disorders, including hemophilia and blood cancers. The report also discusses the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends, and clinical and new developments.

ANALYST’S CREDENTIALS

Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience. She has managed preclinical discovery programs from target identification, including IND enabling studies, and assisted out-licensing and portfolio development activities. Her strong focus areas include oncology, dermatology and cardiovascular diseases. She has extensive experience working with early startups to fulfill operational obligations while minimizing overall operational cost and burden.

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drugs and Diagnostics for Hematological Disorders: Global Markets504Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: HEMATALOGICAL DISORDERS56Free
Chapter- 4: HEMATOLOGICAL CANCERS14Free
Chapter- 5: LEUKEMIA27Free
Chapter- 6: LYMPHOMA15Free
Chapter- 7: MULTIPLE MYELOMA19Free
Chapter- 8: MYELODYSPLASTIC SYNDROMES14Free
Chapter- 9: MYELOPROLIFERATIVE DISORDERS35Free
Chapter- 10: EPIDEMIOLOGY OF HEMATOLOGICAL CANCERS83Free
Chapter- 11: HEMATOLOGY INSTRUMENTS AND REAGENTS: A GLOBAL MARKET PERSPECTIVE33Free
Chapter- 12: GLOBAL MARKET FOR TREATMENTS FOR HEMATOLOGICAL DISORDERS71Free
Chapter- 13: HEMATOLOGICAL CANCER THERAPIES MARKET86Free
Chapter- 14: PATENT LANDSCAPE AND CURRENT DEVELOPMENTS16Free
Chapter- 15: SELECTED COMPANY PROFILES21Free
Chapter- 16: BIBLIOGRAPHY7Free
Published - Mar-2013| Analyst - Usha Nagavarapu| Code - PHM116A

Report Highlights

The total global market for hematological disorder drugs and diagnostics in 2012 was estimated at nearly $72.9 billion. By 2017, the market is expected to reach $99.1 billion, growing at a compound annual growth rate (CAGR) of 6.4% between 2012 and 2017.

Report Includes

  • An overview of the global market for drugs and diagnostics for hematological disorders.
  • Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics.
  • A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies.
  • Delineation of drugs approved by the FDA for hematological disorders.
  • Comprehensive profiles of key companies in the industry.

Drugs and Diagnostics for Hematological Disorders: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS